Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/15276
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWisessmith W.
dc.contributor.authorPhansuwan-Pujito P.
dc.contributor.authorGovitrapong P.
dc.contributor.authorChetsawang B.
dc.date.accessioned2021-04-05T04:33:19Z-
dc.date.available2021-04-05T04:33:19Z-
dc.date.issued2009
dc.identifier.issn7423098
dc.identifier.other2-s2.0-64649097900
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/15276-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-64649097900&doi=10.1111%2fj.1600-079X.2009.00680.x&partnerID=40&md5=57ed2cf999800e2d2083ca22bf6f2222
dc.description.abstractSeveral studies demonstrated that methamphetamine (MA)-treated human neuroblastoma cells exhibit increased oxidative stress, which regulates intracellular signaling cascades leading to cell death. Melatonin has a potential as a direct free radical scavenger and protects against cell death caused by MA. The objective of this study was to investigate the neuroprotective properties of melatonin on MA-induced induction of death signaling cascade and neuronal cell degeneration in human neuroblastoma SH-SY5Y cultured cells. The results of the present study demonstrate that MA significantly reduced cell viability in SH-SY5Y cultured cells. Desipramine, a monoamine uptake blocker, and melatonin reversed the toxic effect of MA in reducing cell viability. Induction of Bax, Bcl-2 and cleaved caspase-3 protein levels were observed in SH-SY5Y cultured cells treated with MA, whereas the induction of Bax and cleaved caspase-3 was diminished by melatonin. Visualization of the induction of Bax using immunofluorescence but a reduction in mitochondrial sites using red-fluorescent mitochondria-staining dye was more obviously apparent in MA-treated cells than in untreated control cells and, again, this effect was abolished by melatonin. These findings demonstrate important roles of Bax and caspase in death signaling cascade, and the protective effects of melatonin in MA-treated SH-SY5Y cells. © 2009 Blackwell Munksgaard.
dc.subjectcaspase 3
dc.subjectdesipramine
dc.subjectmelatonin
dc.subjectmethamphetamine
dc.subjectprotein Bax
dc.subjectprotein bcl 2
dc.subjectarticle
dc.subjectcell protection
dc.subjectcell viability
dc.subjectcontrolled study
dc.subjectenzyme degradation
dc.subjecthuman
dc.subjecthuman cell
dc.subjectmitochondrion
dc.subjectnerve cell degeneration
dc.subjectnerve cell necrosis
dc.subjectneuroblastoma cell
dc.subjectneuroprotection
dc.subjectbcl-2-Associated X Protein
dc.subjectCaspase 3
dc.subjectCell Count
dc.subjectCell Death
dc.subjectCell Line, Tumor
dc.subjectCell Survival
dc.subjectDesipramine
dc.subjectDrug Interactions
dc.subjectHumans
dc.subjectMelatonin
dc.subjectMethamphetamine
dc.subjectMicroscopy, Fluorescence
dc.subjectMitochondria
dc.subjectNeuroblastoma
dc.subjectNeuroprotective Agents
dc.subjectSignal Transduction
dc.titleMelatonin reduces induction of Bax, caspase and cell death in methamphetamine-treated human neuroblastoma SH-SY5Y cultured cells
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationJournal of Pineal Research. Vol 46, No.4 (2009), p.433-440
dc.identifier.doi10.1111/j.1600-079X.2009.00680.x
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.